HomeFBLG • NASDAQ
add
Fibrobiologics Inc
Previous close
$2.41
Day range
$2.35 - $2.66
Year range
$1.08 - $55.00
Market cap
90.11M USD
Avg Volume
190.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.35M | 63.35% |
Net income | -500.00K | 77.20% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.31M | -62.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.83M | -27.30% |
Total assets | 10.47M | -21.28% |
Total liabilities | 7.73M | 180.04% |
Total equity | 2.74M | — |
Shares outstanding | 34.66M | — |
Price to book | 30.12 | — |
Return on assets | -86.48% | — |
Return on capital | -447.17% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -500.00K | 77.20% |
Cash from operations | -2.61M | -128.80% |
Cash from investing | -11.00K | 97.34% |
Cash from financing | 4.47M | 375.64% |
Net change in cash | 1.85M | 402.94% |
Free cash flow | -4.52M | -557.76% |
About
Founded
2021
Headquarters
Website
Employees
10
